Taylor Brian J, Lanke Kjerstin, Banman Shanna L, Morlais Isabelle, Morin Merribeth J, Bousema Teun, Rijpma Sanna R, Yanow Stephanie K
School of Public Health, Katz Group Centre, University of Alberta, Edmonton, Alberta, Canada.
Department of Medical Microbiology, Radboud University Medical Centre, Geert Grooteplein 26-28, Nijmegen, The Netherlands.
Am J Trop Med Hyg. 2017 Aug;97(2):533-543. doi: 10.4269/ajtmh.17-0039. Epub 2017 Jul 19.
We describe a novel one-step reverse transcriptase real-time PCR (direct RT-PCR) for malaria parasites that amplifies RNA targets directly from blood. We developed the assay to identify gametocyte-specific transcripts in parasites from patient blood samples, as a means of monitoring malaria parasite transmission in field settings. To perform the test, blood is added directly to a master mix in PCR tubes and analyzed by real-time PCR. The limit of detection of the assay on both conventional and portable real-time PCR instruments was 100 parasites/mL for 18S rRNA, and 1,000 parasites/mL for asexual (PFE0065W) and gametocyte (PF14_0367, PFGEXP5) mRNA targets. The usefulness of this assay in field studies was explored in samples from individuals living in a high-transmission region in Cameroon. The sensitivity and specificity of the assay compared with a standard two-step RT-PCR was 100% for 18S rRNA on both conventional and portable instruments. For PF14_0367, the sensitivity and specificity were 85.7% and 70.0%, respectively, on the conventional instrument and 78.6% and 90%, respectively, on the portable instrument. The concordance for assays run on the two instruments was 100% for 18S rRNA, and 79.2% for PF14_0367, with most discrepancies resulting from samples with low transcript levels. The results show asexual and sexual stage RNA targets can be detected directly from blood samples in a simple one-step test on a field-friendly instrument. This assay may be useful for monitoring malaria parasite transmission potential in elimination settings, where sensitive diagnostics are needed to evaluate the progress of malaria eradication initiatives.
我们描述了一种用于疟原虫的新型一步法逆转录酶实时PCR(直接RT-PCR),它可直接从血液中扩增RNA靶标。我们开发该检测方法是为了鉴定患者血液样本中疟原虫配子体特异性转录本,作为在现场环境中监测疟原虫传播的一种手段。进行该检测时,将血液直接加入PCR管中的预混液中,然后通过实时PCR进行分析。在传统和便携式实时PCR仪器上,该检测方法对18S rRNA的检测限为100个寄生虫/毫升,对无性体(PFE0065W)和配子体(PF14_0367、PFGEXP5)mRNA靶标的检测限为1000个寄生虫/毫升。在喀麦隆一个高传播地区居住的个体样本中探索了该检测方法在现场研究中的实用性。与标准两步法RT-PCR相比,在传统和便携式仪器上,该检测方法对18S rRNA的敏感性和特异性均为100%。对于PF14_0367,在传统仪器上的敏感性和特异性分别为85.7%和70.0%,在便携式仪器上分别为78.6%和90%。两种仪器上运行的检测结果一致性,对于18S rRNA为100%,对于PF14_0367为79.2%,大多数差异来自转录水平低的样本。结果表明,无性体和有性阶段的RNA靶标可在对现场友好的仪器上通过简单的一步法检测直接从血液样本中检测出来。该检测方法可能有助于在消除疟疾的环境中监测疟原虫传播潜力,在这种环境中需要灵敏的诊断方法来评估疟疾根除计划的进展情况。